Indian Pharma Sector Shows Divergent Growth Trends
· Business · Moneycontrol
The Indian pharmaceutical industry is currently experiencing a two-speed growth pattern, characterized by varying performance levels across different segments. While certain companies are benefiting from robust demand in regulated markets, others face challenges related to pricing pressures and regulatory hurdles. Domestic market growth remains steady, supported by chronic therapy segments and consistent demand for essential medicines. Conversely, export-oriented firms are navigating complex geopolitical landscapes and evolving quality standards in international markets. These trends indicate a shift in how domestic manufacturers are balancing volume-driven growth with value-added innovation.
Why it matters
Investors and stakeholders in the Indian pharma sector must account for this divergence, as it directly impacts the profitability and long-term valuation of companies depending on their exposure to domestic versus international markets.
Read the original report — Moneycontrol
Join us on Telegram
Breaking news the moment it lands. At 10,000 members we ship the Android app.